
NVAX
Healthcare · Biotechnology · $1.41B market cap
$8.53-0.23 (-2.7%)Nov 13, 4:24 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +591.8% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | Before the open | -0.37 | -0.19 | +48.6% |
| Aug 6, 2026 | Before the open | -0.36 | -0.32 | +11.1% |
| May 6, 2026 | Before the open | -0.37 | -0.06 | +83.8% |
| Feb 26, 2026 | Time not confirmed | -0.66 | 0.11 | +116.7% |
| Nov 6, 2025 | Before the open | -1.13 | -0.47 | +58.4% |
| Aug 6, 2025 | Before the open | 0.06 | 0.62 | +933.3% |
| May 8, 2025 | Before the open | 0.71 | 2.93 | +312.7% |
| Feb 26, 2025 | Before the open | -0.51 | -0.52 | -1.2% |
| Nov 12, 2024 | Before the open | -0.75 | -0.76 | -1.3% |
| Aug 8, 2024 | Before the open | 1.70 | 0.99 | -41.8% |
| May 10, 2024 | Before the open | -1.06 | -1.05 | +0.9% |
| Feb 28, 2024 | Before the open | -0.35 | -1.44 | -311.4% |
| Nov 9, 2023 | Before the open | -2.21 | -1.26 |
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and…
| +43.0% |
| Aug 8, 2023 | Before the open | -1.16 | 0.58 | +150.0% |
| May 9, 2023 | Before the open | -3.46 | -3.41 | +1.4% |
| Feb 28, 2023 | After the close | -1.05 | -2.28 | -117.1% |
| Nov 8, 2022 | After the close | 1.59 | -2.15 | -235.2% |
| Aug 8, 2022 | After the close | 5.18 | -6.53 | -226.1% |
| May 9, 2022 | After the close | 2.65 | 2.56 | -3.4% |
| Feb 28, 2022 | After the close | -1.80 | -11.18 | -521.1% |
| Nov 4, 2021 | After the close | -3.55 | -4.31 | -21.4% |
| Aug 5, 2021 | After the close | -3.25 | -4.75 | -46.2% |
| May 10, 2021 | After the close | -3.60 | -3.05 | +15.3% |
| Mar 1, 2021 | After the close | -1.49 | -2.70 | -81.2% |
| Nov 9, 2020 | After the close | 1.73 | -3.21 | -285.5% |
| Aug 10, 2020 | After the close | -0.33 | -0.30 | +9.1% |
| May 11, 2020 | After the close | -0.67 | -0.58 | +13.4% |
| Mar 11, 2020 | After the close | -1.06 | -1.13 | -6.6% |
| Nov 7, 2019 | After the close | -0.89 | -1.11 | -24.7% |
| Aug 7, 2019 | After the close | -1.59 | -1.69 | -6.3% |
| May 2, 2019 | After the close | -2.26 | -2.20 | +2.7% |
| Mar 18, 2019 | After the close | -2.60 | -2.60 | 0.0% |
| Nov 7, 2018 | After the close | -2.52 | -2.40 | +4.8% |
| Aug 8, 2018 | After the close | -2.46 | -2.40 | +2.4% |
| May 9, 2018 | After the close | -2.78 | -2.80 | -0.7% |
| Mar 14, 2018 | After the close | -3.09 | -3.20 | -3.6% |